Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 2Unspecified Adult Solid Tumor, Protocol Specific 1Teratoma 1Neoplasms, Germ Cell and Embryonal 1Endodermal Sinus Tumor 1Carcinoma, Embryonal 1

Interventions

Cisplatin 10Ifosfamide 9Etoposide 9Paclitaxel 8Filgrastim 8Carboplatin 7Bleomycin 7Peripheral Blood Stem Cell Transplantation 4pegfilgrastim 3Radiotherapy 3Magnetic Resonance Spectroscopy 3Granulocyte Colony-Stimulating Factor 3liposomal amphotericin B 2Thiotepa 2Therapeutics 2Specimen Handling 2Mesna 2Cyclophosphamide 2Brentuximab Vedotin 2sargramostim 1pegylated granulocyte colony-stimulating factor 1ixabepilone 1etoposide phosphate 1aldesleukin 1Vincristine 1Vinblastine 1Taxes 1Sunitinib 1Standard of Care 1Second-Look Surgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Carcinoma, Embryonal × Respiratory Physiological Phenomena × Clear all
NCT03067181 2026-05-05

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Children's Oncology Group

Phase 3 Recruiting
1,780 enrolled

Neoplasms, Germ Cell and Embryonal, Teratoma, Carcinoma, Embryonal, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡